Shuangying Liu
Overview
Explore the profile of Shuangying Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Zhou X, Wang W, Zhang M, Sun Y, Hu X, et al.
Hum Reprod Open
. 2024 Jul;
2024(3):hoae041.
PMID: 39040637
Study Question: Do singleton children conceived by ART have a higher asthma risk than naturally conceived (NC) singletons? Summary Answer: The asthma risk was similar for ART-conceived singletons and NC...
2.
Xiang Y, Liu S, Wan S, Chen Q, Song Y, Feng G, et al.
Mol Cell Endocrinol
. 2024 May;
591:112274.
PMID: 38777211
It has been reported that immune factors are associated with the occurrence of polycystic ovary syndrome (PCOS). Interleukin-1 (IL-1) is a member of the interleukin family that widely participates in...
3.
Hu X, Feng G, Chen Q, Sang Y, Chen Q, Wang S, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1353068.
PMID: 38726341
Introduction: Despite the global prevalence of coronavirus disease 2019 (COVID-19), limited research has been conducted on the effects of SARS-CoV-2 infection on human reproduction. The aims of this study were...
4.
Bai L, Xiang Y, Tang M, Liu S, Chen Q, Chen Q, et al.
Nat Commun
. 2023 Oct;
14(1):6532.
PMID: 37848452
N-methyladenosine (mA) maintains maternal RNA stability in oocytes. One regulator of mA, ALKBH5, reverses mA deposition and is essential in RNA metabolism. However, the specific role of ALKBH5 in oocyte...
5.
Feng S, Wan S, Liu S, Wang W, Tang M, Bai L, et al.
Oxid Med Cell Longev
. 2022 May;
2022:5501346.
PMID: 35585880
Several studies have indicated that mutations of LARS2 are associated with premature ovarian insufficiency (POI). However, the pathogenic mechanism of LARS2 in POI has not been reported yet. In the...
6.
Ji F, Liao H, Pan S, Ouyang L, Jia F, Fu Z, et al.
Cell Res
. 2020 Jun;
30(11):1009-1023.
PMID: 32561861
Common fragile sites (CFSs) are genomic loci prone to the formation of breaks or gaps on metaphase chromosomes. They are hotspots for chromosome rearrangements and structural variations, which have been...
7.
Zhang S, Anjum R, Squillace R, Nadworny S, Zhou T, Keats J, et al.
Clin Cancer Res
. 2016 Nov;
22(22):5527-5538.
PMID: 27780853
Purpose: Non-small cell lung cancers (NSCLCs) harboring ALK gene rearrangements (ALK) typically become resistant to the first-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) crizotinib through development of secondary...
8.
Huang W, Liu S, Zou D, Thomas M, Wang Y, Zhou T, et al.
J Med Chem
. 2016 May;
59(10):4948-64.
PMID: 27144831
In the treatment of echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase positive (ALK+) non-small-cell lung cancer (NSCLC), secondary mutations within the ALK kinase domain have emerged as a major resistance...
9.
Kohlmann A, Zech S, Li F, Zhou T, Squillace R, Commodore L, et al.
J Med Chem
. 2013 Jan;
56(3):1023-40.
PMID: 23302067
Lactate dehydrogenase A (LDH-A) catalyzes the interconversion of lactate and pyruvate in the glycolysis pathway. Cancer cells rely heavily on glycolysis instead of oxidative phosphorylation to generate ATP, a phenomenon...
10.
Thomas M, Huang W, Wen D, Zhu X, Wang Y, Metcalf C, et al.
Bioorg Med Chem Lett
. 2011 May;
21(12):3743-8.
PMID: 21561767
Ponatinib (AP24534) was previously identified as a pan-BCR-ABL inhibitor that potently inhibits the T315I gatekeeper mutant, and has advanced into clinical development for the treatment of refractory or resistant CML....